Literature DB >> 35078795

Attitudes toward deprescribing for hospital inpatients.

Richard Gilpin1, Olwen C McDade2, Chris Edwards3.   

Abstract

Clinicians are responsible for both commencing and stopping medications. This study evaluates the attitudes of older acute medical inpatients about deprescribing. Overall, patients are positive toward stopping medications, want to be involved and do not feel a clinician is giving up on them if a medication is stopped. Patients on fewer medications counterintuitively feel a greater medication burden, are more interested in being involved in decision making and consider deprescribing appropriate to a greater degree than patients who are taking more medications. Conversely, they also reported greater concerns about stopping medications. We discuss these findings in the context of the positive and negative effects of deprescribing, in the context of patient engagement and shared decision making, and how clinicians can work with inpatients to reduce potentially inappropriate medications. © Royal College of Physicians 2022. All rights reserved.

Entities:  

Keywords:  adverse effects; deprescribing; medications

Mesh:

Year:  2022        PMID: 35078795      PMCID: PMC8813024          DOI: 10.7861/clinmed.2021-0445

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  29 in total

Review 1.  Predicting risk of adverse drug reactions in older adults.

Authors:  Amanda Hanora Lavan; Paul Gallagher
Journal:  Ther Adv Drug Saf       Date:  2016-02

2.  Too much medicine in older people? Deprescribing through shared decision making.

Authors:  Jesse Jansen; Vasi Naganathan; Stacy M Carter; Andrew J McLachlan; Brooke Nickel; Les Irwig; Carissa Bonner; Jenny Doust; Jim Colvin; Aine Heaney; Robin Turner; Kirsten McCaffery
Journal:  BMJ       Date:  2016-06-03

3.  Relationships as Medicine: Quality of the Physician-Patient Relationship Determines Physician Influence on Treatment Recommendation Adherence.

Authors:  Heather Orom; Willie Underwood; Zinan Cheng; D Lynn Homish; I'Yanna Scott
Journal:  Health Serv Res       Date:  2016-12-15       Impact factor: 3.402

4.  Impact of deprescribing rounds on discharge prescriptions: an interventional trial.

Authors:  Rachel Edey; Nicholas Edwards; Jonah Von Sychowski; Ajay Bains; Jim Spence; Dan Martinusen
Journal:  Int J Clin Pharm       Date:  2018-11-27

5.  Attitudes of Older Adults and Caregivers in Australia toward Deprescribing.

Authors:  Emily Reeve; Lee-Fay Low; Sarah N Hilmer
Journal:  J Am Geriatr Soc       Date:  2019-02-13       Impact factor: 5.562

6.  Reducing inappropriate polypharmacy: the process of deprescribing.

Authors:  Ian A Scott; Sarah N Hilmer; Emily Reeve; Kathleen Potter; David Le Couteur; Deborah Rigby; Danijela Gnjidic; Christopher B Del Mar; Elizabeth E Roughead; Amy Page; Jesse Jansen; Jennifer H Martin
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

7.  Deprescribing guidelines: An international symposium on development, implementation, research and health professional education.

Authors:  Barbara Farrell; James Conklin; Lisa Dolovich; Hannah Irving; Malcolm Maclure; Lisa McCarthy; Frank Moriarty; Kevin Pottie; Lalitha Raman-Wilms; Emily Reeve; Wade Thompson
Journal:  Res Social Adm Pharm       Date:  2018-09-18

Review 8.  Medication withdrawal trials in people aged 65 years and older: a systematic review.

Authors:  Shoba Iyer; Vasi Naganathan; Andrew J McLachlan; David G Le Couteur
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

9.  Potentially Inappropriate Medications in Older Adults: Deprescribing with a Clinical Pharmacist.

Authors:  Catherine A Ammerman; Brent A Simpkins; Nora Warman; Tara N Downs
Journal:  J Am Geriatr Soc       Date:  2018-10-09       Impact factor: 5.562

10.  Potentially inappropriate medication and attitudes of older adults towards deprescribing.

Authors:  Alexandra B Achterhof; Zsofia Rozsnyai; Emily Reeve; Katharina Tabea Jungo; Carmen Floriani; Rosalinde K E Poortvliet; Nicolas Rodondi; Jacobijn Gussekloo; Sven Streit
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.